Abstract
We previously demonstrated that loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death by inducing mitochondrial permeability transition pore (mPTP) opening (Oncogene 37, 1788–1804). However, the molecular mechanism by which Cdk5 loss causes mPTP opening remains to be investigated. Using primary mouse embryonic fibroblasts (MEFs) isolated from Cdk5−/− mouse embryos, we show that absence of Cdk5 causes a significant increase in both mPTP opening and mitochondrial Ca2+ level. Analysis of subcellular fractions of MEFs demonstrates that Cdk5 localizes in the mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) and Cdk5 loss in MAMs causes increased ER-mitochondria tethering, a process required for Ca2+ transfer from the ER to the mitochondria. Loss of Cdk5 also causes increased ATP-mediated mitochondrial Ca2+ uptake from the ER. Inhibition of ER Ca2+ release or mitochondrial Ca2+ uptake in Cdk5−/− MEFs prevents mPTP opening, indicating that mPTP opening in Cdk5−/− MEFs is due to increased Ca2+ transfer from the ER to the mitochondria. Altogether, our findings suggest that Cdk5 in MAMs regulates mitochondrial Ca2+ homeostasis that is disturbed upon Cdk5 loss, which leads to mPTP opening.
Similar content being viewed by others
Introduction
Cyclin dependent kinase 5 (Cdk5) is a small proline-directed serine/threonine kinase that serves various cell functions such as in the regulation of oxidative stress [1, 2], mitochondrial functions [3] and apoptosis [4, 5]. We previously reported that loss of Cdk5 promotes mitochondrial permeability transition pore (mPTP)-mediated apoptosis in breast cancer cells [6]. We found that Cdk5 loss induces mPTP opening, which leads to increased cellular levels of reactive oxygen species (ROS) that subsequently cause increased susceptibility of breast cancer cells to apoptosis. However, the fundamental mechanism by which loss of Cdk5 regulates mPTP opening is unclear.
Mitochondria are cell organelles that execute a number of key cellular functions, including in energy conversion, intermediate cellular metabolism, cell differentiation, immune response, calcium signaling and homeostasis, and cell death. While the outer mitochondrial membrane (OMM) is highly permeable to Ca2+, the inner mitochondrial membrane (IMM) contains the mitochondrial calcium uniporter (MCU) complex that regulates mitochondrial calcium ([Ca2+]mt) influx [7]. As MCU has low affinity to Ca2+ with Kd of ~10 μM, high Ca2+ concentration is needed for MCU activity [8]. Mitochondrial uptake of Ca2+ through MCU channels is facilitated by the close proximity of the mitochondria to the endoplasmic reticulum (ER) [9, 10]. A common mechanism by which mitochondria communicate with the ER is through the interface between these two organelles, which is designated as the mitochondria-associated ER membrane (MAM) [11]. MAM regulates transport of lipids, calcium and other metabolites from the ER to the mitochondria [12, 13], and is involved in the regulation of mitochondrial dynamics [14, 15], formation of autophagosomes and cell survival [16, 17]. MAM consists of inositol 1,4,5-trisphosphate receptors (IP3Rs), voltage-dependent anion channels (VDACs), glucose-regulated protein 75 kDa (Grp75), glucose- regulated protein 78 kDa (Grp78) [18], mitofusin 2 (Mfn2), long-chain fatty acid-CoA ligase 4 (FACL-4), phosphofurin acidic cluster sorting protein 2 (PACS-2), B-cell receptor-associated protein 31 (Bap31) and mitochondrial fission 1 protein (Fis1) [19], and contains a high concentration of calcium [20]. Once Ca2+ is released from the ER to the cytoplasm via the IP3R channels, part of the released Ca2+ is taken up by the mitochondria [21] through the VDACs in the OMM, and the MCU channels in the IMM [10, 22]. Several studies show rapid Ca2+ mobilization from IP3-gated channels to nearby mitochondria, resulting in increased [Ca2+]mt concentration [23,24,25]. The ER is closely tethered to approximately 5–20% of mitochondrial surface within a 10–30 nm space [26, 27]. This distinct structure is crucial for intracellular calcium homeostasis. Thus, disruption of MAM causes deregulation of calcium mobilization and disruption of [Ca2+]mt homeostasis.
Under physiological conditions, a small rise in mitochondrial Ca2+ concentration leads to increased mitochondrial respiratory chain activity and ATP synthesis [28, 29]. However, pathological mitochondrial calcium overload is associated with increased generation of ROS, mitochondrial depolarization and increased or prolonged mPTP opening [28,29,30]. The voltage-dependent, high-conductance mPTP channel controls permeabilization of the IMM. While transient opening of mPTP is thought to be a calcium efflux channel in the mitochondria under normal conditions [31, 32], prolonged mPTP opening causes mitochondrial swelling and release of cytochrome C and other intermembrane space (IMS) proteins, leading to activation of caspase-mediated apoptosis [33, 34].
In this study, we used Cdk5−/− mouse embryonic fibroblasts (MEFs) to investigate how Cdk5 loss induces mPTP opening. We demonstrate that loss of Cdk5 alters ER-mitochondria tethering, increasing mitochondrial Ca2+ uptake from the ER. We propose that Cdk5 loss alters mitochondrial Ca2+ homeostasis, causing mPTP opening.
Results
Cdk5 loss in primary MEFs induces mPTP opening
Previously, we demonstrated that knocking down Cdk5 by siRNA in breast cancer cells causes mPTP opening and subsequent ROS increase, which promotes cell death [6]. To further characterize the molecular and cellular mechanisms that lead to mPTP opening upon Cdk5 loss, we utilized primary MEFs isolated from wt and Cdk5−/− mouse embryos as knockout of the Cdk5 gene in mice is associated with perinatal lethality [39]. Initially, we assessed mPTP opening in Cdk5−/− MEFs by calcein-AM staining followed by treatment with CoCl2. Calcein-AM is a cell permeable fluorophore that diffuses and gets trapped in all subcellular compartments, including mitochondria [40]. Treatment with cobalt (Co2+) quenches calcein fluorescence in all subcellular compartments except the mitochondrial matrix which is enclosed by a Co2+ impermeable inner mitochondrial membrane when mPTP is closed. Thus, the ability of Co2+ to quench mitochondrial calcein fluorescence only when mPTP is open allows determination of open vs closed status of mPTP in the cell [40]. As shown in Fig. 1a, fluorescence microscopy of wt and Cdk5−/− MEFs following calcein staining without CoCl2 treatment showed strong and similar fluorescence intensity, indicating equivalent intracellular calcein-AM loading. However, upon treatment with CoCl2, Cdk5−/− MEFs exhibited less calcein fluorescence intensity compared with wt, indicating greater quenching of mitochondrial calcein fluorescence and thus increased mPTP opening in Cdk5−/− MEFs compared with wt. Consistent with these observations, flow cytometry analyses of CoCl2-treated cells pre-stained with calcein (Fig. 1b, top and bottom panels) showed that Cdk5−/− MEFs have reduced (p < 0.05) calcein fluorescence intensity compared to wt (0.25 vs 0.52). The clear decline in calcein-stained population of Cdk5−/− MEFs further indicates greater mPTP opening in these cells compared with wt.
Loss of Cdk5 in MEFs causes increased level of [Ca2+]mt
A rise in mitochondrial Ca2+ level, [Ca2+]mt, has been shown to be a critical regulator of mPTP opening [41]. Thus, we sought to examine potential alteration in [Ca2+]mt in Cdk5−/− MEFs by tracing cytoplasmic Ca2+ level, [Ca2+]cyt, following the addition of the protonophore and oxidative phosphorylation uncoupler, FCCP. FCCP causes depolarization or collapse of the mitochondrial membrane potential, resulting in mPTP opening and release of Ca2+ from the mitochondria [42]. Therefore, the increase in cytoplasmic Ca2+ level following FCCP treatment in wt as well as Cdk5−/− MEFs corresponds to [Ca2+]mt. To proceed with [Ca2+]mt measurement, wt and Cdk5−/− MEFs loaded with the cell-permeable intracellular calcium indicator, Fluo-4-AM, were subjected to single cell Ca2+ imaging before and after FCCP treatment. As shown in Fig. 2a, treatment with FCCP caused a greater wave of increase in [Ca2+]cyt in Cdk5−/− MEFs than in wt, indicating increased [Ca2+]mt in Cdk5−/− MEFs compared with wt. Quantitative analyses revealed a 58% increase (p < 0.05) in peak amplitude (Fig. 2b) and a twofold increase (p < 0.05) in area under the curve (Fig. 2c) in Cdk5−/− MEFs compared with wt further indicating increased [Ca2+]mt in Cdk5−/− MEFs.
Cdk5 is a mitochondria-associated ER membrane (MAM) protein, which when lost induces ER-mitochondria tethering
The ER is the major intracellular Ca2+ store, and the interface between the ER and the mitochondria, named mitochondria-associated ER membrane (MAM), contains channels for calcium transfer [21]. As shown in Fig. 3a, Cdk5 exists in MAMs purified from wt MEFs. Cdk5 as a MAM protein was supported by co-fractionation with the ER-MAM markers, fatty acid-CoA ligase long-chain (FACL4) and glucose-regulated protein 78 kDa (GRP78), and the mitochondria-MAM marker, voltage-dependent anion channel (VDAC). Purity of the isolated MAMs was further assessed by the lack of the nuclear and cytoplastic markers, proliferating cell nuclear antigen (PCNA) and lactate dehydrogenase (LDH), respectively.
ER-mitochondria tethering is essential for the formation of ER-mitochondria contact sites and subsequent Ca2+ transfer from the ER to the mitochondria [43, 44]. To investigate the possibility that ER-mitochondria tethering and contact sites are altered in Cdk5−/− MEFs, causing an increase in [Ca2+]mt, ultrathin sections of wt and Cdk5−/− MEFs were subjected to TEM (Fig. 3b) as described in the Materials and Methods section. Since the number, length and distance between the ER-mitochondria contact sites have been shown to influence ER Ca2+ transfer to the mitochondria [43, 45, 46], we analyzed these parameters in wt and Cdk5−/− MEFs. As shown in Fig. 3c, the percentage of mitochondria that is in contact with the ER is higher (p < 0.05) in Cdk5−/− MEFs than in wt (67% vs 52 %). Figure 3d shows that the mitochondrial perimeter that is in contact with the ER in Cdk5−/− MEFs is also greater (p < 0.01) in Cdk5−/− MEFs than in wt (40% vs 15%). In addition, as shown in Fig. 3e, the percentage of ER-mitochondria contact sites with a distance of <30 nm is higher (p < 0.05) in Cdk5−/− MEFs compared with wt (44% vs 25%).
Loss of Cdk5 causes increased mitochondrial Ca2+ uptake from the ER upon stimulation with ATP
Our next approach was to examine a potential difference in mitochondrial Ca2+ uptake from the ER in wt and Cdk5−/− MEFs. To do so, cells in Ca2+-free buffer and pre-loaded with a mitochondrial Ca2+ probe, Rhod-2 AM [47], were treated with ATP, which binds cell surface purinergic receptors [48] and IP3R [49], which both stimulate IP3-evoked ER Ca2+ release [49]. As shown in Fig. 4a, treatment with ATP caused a greater wave of increase in [Ca2+]mt in Cdk5−/− MEFs than in wt. Quantitative analyses showed a 26% increase (p < 0.05) in peak amplitude (Fig. 4b), and a 69% increase in integrated Ca2+ signal (Fig. 4c) in Cdk5−/− MEFs compared to wt. In addition, the rate of Ca2+ influx into the mitochondria was 33% faster in Cdk5−/− MEFs compared to wt (Fig. 4d) while the rate of Ca2+ extrusion from the mitochondria was slower by 75% in Cdk5−/− MEFs compared to wt (Fig. 4e). Together, our data indicate that Cdk5−/− MEFs have increased and prolonged ATP-induced mitochondrial Ca2+ uptake from the ER compared to wt.
mPTP opening due to Cdk5 loss is blocked by inhibition of ER Ca2+ release or mitochondrial calcium uptake
We then investigated whether inhibition of either ER Ca2+ release with the potent IP3R inhibitor, XeC [50, 51], or mitochondrial calcium uptake with the potent MCU inhibitor, RuR [52], followed by calcein-AM loading and subsequent treatment with CoCl2 would show blockade of increased mPTP opening in Cdk5−/− MEFs. Consistent with our data in Fig. 1, flow cytometry analyses shown in Fig. 5, a, b demonstrate that Cdk5−/− MEFs exhibited less calcein fluorescence intensity compared to wt, indicating greater Co2+ quenching of mitochondrial calcein fluorescence and thus increased mPTP opening in Cdk5−/− MEFs compared to wt. However, treatment with XeC or RuR increased the calcein fluorescence intensity in Cdk5−/− MEFs to a level equivalent to that of wt. Treatment with the potent mPTP desensitizers, CsA [53] or SFA [54] also completely prevented mPTP opening in Cdk5−/− MEFs. Cells untreated with CoCl2 and cells treated with ionomycin served as controls. Altogether, we demonstrate that inhibition of either ER Ca2+ release or mitochondrial calcium uptake prevents mPTP opening in Cdk5−/− MEFs, further indicating that mPTP opening due to loss of Cdk5 results from increased ER Ca2+ transfer to mitochondria.
Discussion
We now know that loss of Cdk5 in breast cancer cells causes increased mPTP opening that is associated with mitochondrial depolarization, increased ROS levels, mitochondrial fragmentation and apoptosis [6]. Furthermore, we determined that the mPTP-mediated apoptotic pathway in breast cancer cells is coupled with an increase in both intracellular [Ca2+] level and calcineurin activity [6]. In the current study, we identify a novel mechanism by which loss of Cdk5 promotes mPTP opening. Figure 6 illustrates that Cdk5 loss in Cdk5−/− MEFs causes an increase in number and length of ER-mitochondrial contact sites as well as a decrease in gaps between these contact sites. These changes promote an increase in mitochondrial Ca2+ uptake from the ER, causing increased [Ca2+]mt and subsequent increase in mPTP opening upon loss of Cdk5.
mPTP is a calcium-dependent and CsA-sensitive high-conductance channel. mPTP opening induces permeability of the IMM due to the opening of its pore forming proteins. The components of mPTP and the pore-forming proteins remain unresolved. Nonetheless, several studies implicate physiological roles of mPTP in Ca2+ buffering, energy metabolism, and mitochondrial homeostasis. Our group [6] and others [33, 34, 55, 56] also showed that increased or prolonged mPTP opening results in mitochondrial depolarization, increased ROS generation, inhibition of ATP synthesis, and release of apoptosis-inducing mitochondrial proteins such as cytochrome C and apoptosis inducing factor, causing activation of the caspase-mediated apoptotic pathway. We observed these mPTP opening-induced characteristics in breast cancer cells lacking Cdk5 but Cdk5−/− MEFs also exhibit increased mPTP opening, which is reversed by mPTP desensitizers such as CsA and SFA and show increased [Ca2+]mt level that has been shown to induce mPTP opening. As with breast cancer cells depleted of Cdk5 by siRNA, we determined here that Cdk5−/− MEFs exhibit increased mPTP opening that is reversed by the mPTP desensitizers, CsA and SFA, and show increased [Ca2+]mt level that induces mPTP opening. It is interesting, however, that while loss of Cdk5 in breast cancer cells promote apoptosis, we observed that Cdk5−/− MEFs show increased proliferation (data not shown). This was unexpected but supports differential physiology and roles of Cdk5 in normal and cancer cells, and calls for more comprehensive investigations on the function of Cdk5 in mitochondrial calcium dynamics in normal and disease conditions.
MAM, a proteinaceous link between the ER and mitochondria, is important for calcium and metabolite transfer between these organelles. In this study, we show that Cdk5 is enriched in pure MAM fractions, a finding that is consistent with the mass spectrometry analysis by Poston et al., identifying, with high confidence, Cdk5 as one of the MAM proteins in mouse brain [57]. For effective calcium transfer, MCU channels require close ER-mitochondria apposition that is influenced by the ER-mitochondria contact site number, length and distance. The ER-mitochondria contact sites allow the rapid transfer of large amounts of Ca2+ from the ER to the mitochondria upon opening of the IP3-gated channels [23, 24, 58]. The distance from the OMM to the rough and smooth ER was determined to be 10–30 nm and 9–16 nm respectively [45, 59], and about 5–20% of the mitochondrial surface is closely apposed to the ER [26, 27]. Our studies show that in wt cells, the ER is juxtaposed to 15% of the mitochondrial surface whereas loss of Cdk5 increases the ER-mitochondrial juxtaposition to about 40%. Similarly, the percentage of ER-mitochondria contacts within ≤30 nm is higher in the absence of Cdk5. Since disruption in ER-mitochondria tethering alters Ca2+ transfer between the ER and the mitochondria [60], it is not surprising that we observed increased ATP-induced mitochondrial calcium uptake in cells lacking Cdk5. Similarly, prolonged extrusion of mitochondrial Ca2+ in the absence of Cdk5 is expected to contribute to [Ca2+]mt accumulation and subsequent mPTP opening. Nevertheless, our observations indicate that Cdk5 in MAM serves to control ER-mitochondrial tethering, and loss of Cdk5 causes an upsurge in mitochondrial calcium uptake by increasing ER-mitochondrial tethering. While studies are underway to further characterize the specific role of MAM Cdk5 in ER-mitochondria tethering, our finding that inhibition of either ER Ca2+ release with XeC or mitochondrial calcium uptake with RuR blocks the increase in mPTP opening induced by Cdk5 loss suggests that elevated mitochondrial calcium influx underlies the increase in mPTP opening in the absence of Cdk5. Altogether, our studies demonstrate a novel mechanism whereby Cdk5 controls mPTP opening by regulating the formation of ER-mitochondria contact site structures and subsequently, calcium transfer from the ER to the mitochondria and [Ca2+]mt level.
Materials and methods
Materials
Dulbecco’s modified eagle’s medium (DMEM), heat-inactivated fetal bovine serum (FBS), EDTA-Trypsin, antibiotic-antimycotic, Calcein AM, Fluo-4 AM and Rhod-2 AM were from Life Technologies Inc. The protease inhibitor cocktail, Cyclosporine A (CsA), Ruthenium Red (RuR), ATP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) and Xestospongin C (XeC) were from Sigma. Antibodies to Cdk5 (C-8), FACL-4 (F-4), VDAC1 (B-6), GRP78 (A-10), PCNA (PC-10) and LDH-A (E-9) were from Santa Cruz Biotech. Sanglifehrin A (SFA) was a gift from Novartis (Switzerland).
Primary MEF isolation and culture
Primary MEFs were isolated from E13.5 wt and Cdk5−/− mouse embryos following the protocol described by Durkin et al. [35] which was based on the method by Todaro and Green [36] and subsequent modifications of the technique by Coats et al. [37]. Embryos were from Cdk5+/− pregnant female mice crossed with Cdk5+/− male mice. Embryos were washed with (phosphate-buffered saline) PBS, decapitated and eviscerated then washed again with PBS. Embryos were minced with sterile forceps and placed in 3–5 ml of 0.05% trypsin-EDTA, pipetted up and down to get cells into suspension and incubated at 37 °C for 5 min. Cell suspensions were transferred to new tubes containing MEF medium (DMEM-high glucose supplemented with 10% FBS, 1% penicillin-streptomycin and 2 mM GlutaMAX) then centrifuged at 1,000 rpm for 5 min. Cell pellets were resuspended in fresh media and plated in 10 cm cell culture dishes. Primary MEFs were cultured in DMEM supplemented with 10% FBS and 100 U/ml each of penicillin and streptomycin under hypoxic condition (5% O2 and 5% CO2 incubator). All experiments were performed in passage P2-P7 MEFs.
Transmission electron microscopy
TEM analysis was performed following fixation, dehydration, infiltration, and embedding of wt and Cdk5−/− MEFs in situ. Ultra-thin (~60 nm) sections were cut and stained with 2% uranyl acetate and lead citrate and observed under a Hitachi H7650 TEM at the University of Calgary’s Microscopy and Imaging Facility. Images were acquired through an AMT 16000 CCD mounted on the microscope.
MAM and mitochondria isolation
Crude and pure MAMs, and mitochondria were isolated using Percoll density gradient centrifugation as described previously [38]. Briefly, trypsinized MEFs were homogenized in 10 ml of IBcells-1 buffer containing 225 mM mannitol, 75 mM sucrose, 0.1 mM EGTA, and 30 mM Tris–HCl (pH 7.4). Homogenates (H) were centrifuged at 600 × g for 5 min at 4 °C. The resulting supernatants were subjected to further centrifugation at 7000 × g for 10 min at 4 °C. Pellets were resuspended in 10 ml of IBcells-2 buffer containing 225 mM mannitol, 75 mM sucrose and 30 mM Tris–HCl (pH 7.4) followed by centrifugation at 7000 × g for 10 min at 4 °C. Pellets containing MAM and mitochondria were resuspended again in 10 ml of IBcells-2 buffer and centrifuged at 10,000 × g for 10 min at 4 °C. The resulting pellets were resuspended in 2 ml of mitochondria resuspending buffer (MRB: 250 mM mannitol, 0.5 mM EGTA and 5 mM HEPES, pH 7.4). The crude mitochondria were then layered with 8 ml of Percoll medium [225 mM mannitol, 25 mM HEPES (pH 7.4), 1 mM EGTA and 30% Percoll] and 4 ml of MRB then centrifuged at 95,000 × g for 30 min at 4 °C. Pure mitochondria (MT) settles at the bottom of the tube while the MAM fraction appears as a white band above the MT fraction. The MAM and MT fractions were each resuspended in 14 ml of MRB buffer and centrifuged at 6300 × g for 10 min at 4 °C. The resulting supernatants (~14 ml) of the MAM fraction, designated as crude MAM (C-MAM), were further subjected to centrifugation at 100,000 × g for 1 hr. Pellets containing pure MAM (P-MAM) or pure MT were each resuspended in 50 µl of MRB buffer.
Western blotting
Isolated subcellular fractions (50 µl) were loaded in 12.5% SDS polyacrylamide gels and transferred onto nitrocellulose membranes. Membranes were blocked in 5% skimmed milk then incubated with the indicated primary antibody (1:1000 dilution) at 4 °C overnight. After washing with Tris-buffered saline (TBS) + Tween-20 (TBST) (50 mM Tris–HCl, pH 7.6, 0.1% Tween-20, 0.8% NaCl), membranes were incubated with horseradish peroxidase-conjugated secondary antibody (1:10,000 dilution) for 1 h. Immunoreactive bands were detected using ECL reagent (Amersham).
mPTP opening assay
Calcein fluorescence was measured using the Image-IT live mitochondria permeability transition pore assay kit (Thermo Fisher Sci.) as per the manufacturer’s protocol. Briefly, cells seeded on a four-chamber cover glass (Lab-Tek) were loaded with calcein AM (1 µM), MitoTracker Red (200 nM), treated with or without CoCl2 (1 mM) in Hank’s balanced salt solution (HBSS), and incubated for 15 min at 37 °C under 5% CO2. Cells were then washed with HBSS buffer and images were taken under an Olympus 1 × 71 fluorescence microscope using a ×10 objective with or without the ×1.6 magnification changer.
For flow cytometry, cells (1 × 104) were harvested using Trypsin-EDTA and pre-incubated with CsA (1 µM), SFA (2 µM), XeC (3 µM) or RuR (3 µM) for 1 h then stained as indicated above. Cells were then washed with HBSS, resuspended in ice-cold PBS and analyzed by flow cytometry using a fluorescein isothiocyanate filter (530 nm) for measuring calcein fluorescence.
Calcium measurement
For cytoplasmic Ca2+ measurements, MEFs seeded on 3.5 cm glass bottom petri dishes (80% confluency) were loaded with Fluo-4 AM (5 µM) in HBSS (with 1.26 mM calcium) for 30 min at RT. Cells were washed three times with KRH buffer (125 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 25 mM HEPES, 6 mM glucose) then subjected to single cell calcium imaging using a Leica TCS SP8 confocal microscope (×20 objective). Fluorescence signals were quantified as ratio (F/F0) of the fluorescence after addition of FCCP, relative to the basal fluorescence (F0) before stimulation.
For mitochondrial Ca2+ measurements, MEF cells seeded on 3.5 cm glass bottom petri dishes (80% confluency) were loaded with Rhod-2 AM (5 µM) in KRH buffer (125 mM NaCl, 5 mM KCl, 25 mM HEPES, 6 mM glucose) for 30 min at RT. Cells washed three times with KRH buffer were subjected to single cell calcium imaging using a Zeiss LSM 510 Meta laser scanning confocal microscope (×20 objective). Fluorescence signals were quantified as ratio (F/F0) of the fluorescence after addition of ATP, relative to the basal fluorescence (F0) before stimulation.
Statistical analysis
Student’s t test (unpaired, two-sided) was used. Significance was set at p < 0.05.
References
Sun KH, de Pablo Y, Vincent F, Shah K. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J Neurochem. 2008;107:265–78.
Qu D, Rashidian J, Mount MP, Aleyasin H, Parsanejad M, Lira A, et al. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson’s disease. Neuron. 2007;55:37–52.
Fitzgerald JC, Camprubi MD, Dunn L, Wu HC, Ip NY, Kruger R, et al. Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. Cell Death Differ. 2012;19:257–66.
Meuer K, Suppanz IE, Lingor P, Planchamp V, Goricke B, Fichtner L, et al. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ. 2007;14:651–61.
Weishaupt JH, Kussmaul L, Grotsch P, Heckel A, Rohde G, Romig H, et al. Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction. Mol Cell Neurosci. 2003;24:489–502.
NavaneethaKrishnan S, Rosales JL, Lee KY. Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore. Oncogene. 2018;37:1788–804.
Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat Rev Mol Cell Biol. 2018;19:713–30.
Paupe V, Prudent J. New insights into the role of mitochondrial calcium homeostasis in cell migration. Biochem Biophys Res Commun. 2018;500:75–86.
Grimm S. The ER-mitochondria interface: the social network of cell death. Biochim Biophys Acta. 2012;1823:327–34.
Rizzuto R, Marchi S, Bonora M, Aguiari P, Bononi A, De Stefani D, et al. Ca(2+) transfer from the ER to mitochondria: when, how and why. Biochim Biophys Acta. 2009;1787:1342–51.
Vance JE. MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. Biochim Biophys Acta. 2014;1841:595–609.
Wiedemann N, Meisinger C, Pfanner N. Cell biology. Connecting organelles. Science. 2009;325:403–4.
Hayashi T, Rizzuto R, Hajnoczky G, Su TP. MAM: more than just a housekeeper. Trends Cell Biol. 2009;19:81–88.
Tagaya M, Arasaki K. Regulation of mitochondrial dynamics and autophagy by the mitochondria-associated membrane. Adv Exp Med Biol. 2017;997:33–47.
Ortiz-Sandoval CG, Hughes SC, Dacks JB, Simmen T. Interaction with the effector dynamin-related protein 1 (Drp1) is an ancient function of Rab32 subfamily proteins. Cell Logist. 2014;4:e986399.
Patergnani S, Missiroli S, Marchi S, Giorgi C. Mitochondria-associated endoplasmic reticulum membranes microenvironment: targeting autophagic and apoptotic pathways in cancer therapy. Front Oncol. 2015;5:173.
Bravo-Sagua R, Rodriguez AE, Kuzmicic J, Gutierrez T, Lopez-Crisosto C, Quiroga C, et al. Cell death and survival through the endoplasmic reticulum-mitochondrial axis. Curr Mol Med. 2013;13:317–29.
Ma JH, Shen S, Wang JJ, He Z, Poon A, Li J, et al. Comparative proteomic analysis of the mitochondria-associated ER membrane (MAM) in a long-term type 2 diabetic rodent model. Sci Rep. 2017;7:2062.
Michel AH, Kornmann B. The ERMES complex and ER-mitochondria connections. Biochem Soc Trans. 2012;40:445–50.
Csordas G, Varnai P, Golenar T, Roy S, Purkins G, Schneider TG, et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol Cell. 2010;39:121–32.
Patergnani S, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, et al. Calcium signaling around Mitochondria Associated Membranes (MAMs). Cell Commun Signal. 2011;9:19.
Shoshan-Barmatz V, De S, Meir A. The mitochondrial voltage-dependent anion channel 1, Ca(2+) transport, apoptosis, and their regulation. Front Oncol. 2017;7:60.
Rizzuto R, Brini M, Murgia M, Pozzan T. Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science. 1993;262:744–7.
Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 1998;280:1763–6.
Decuypere JP, Monaco G, Missiaen L, De Smedt H, Parys JB, Bultynck G. IP(3) receptors, mitochondria, and Ca signaling: implications for aging. J Aging Res. 2011;2011:920178.
Liu Y, Zhu X. Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases. Transl Neurodegener. 2017;6:21.
Gomez-Suaga P, Paillusson S, Stoica R, Noble W, Hanger DP, Miller CCJ. The ER-mitochondria tethering complex VAPB-PTPIP51 regulates autophagy. Curr Biol. 2017;27:371–85.
Finkel T, Menazza S, Holmstrom KM, Parks RJ, Liu J, Sun J, et al. The ins and outs of mitochondrial calcium. Circ Res. 2015;116:1810–9.
Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol. 2000;529(Pt 1):57–68.
Contreras L, Drago I, Zampese E, Pozzan T. Mitochondria: the calcium connection. Biochim Biophys Acta. 2010;1797:607–18.
Altschuld RA, Hohl CM, Castillo LC, Garleb AA, Starling RC, Brierley GP. Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. Am J Physiol. 1992;262:H1699–1704.
Ichas F, Jouaville LS, Mazat JP. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell. 1997;89:1145–53.
Kinnally KW, Peixoto PM, Ryu SY, Dejean LM. Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim Biophys Acta. 2011;1813:616–22.
Lemasters JJ, Qian T, He L, Kim JS, Elmore SP, Cascio WE, et al. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal. 2002;4:769–81.
Durkin ME, Qian X, Popescu NC, Lowy DR. Isolation of mouse embryo fibroblasts. Bio Protoc 2013;3:e908.
Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963;17:299–313.
Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, et al. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr Biol. 1999;9:163–73.
Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc. 2009;4:1582–90.
Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA. 1996;93:11173–8.
Petronilli V, Miotto G, Canton M, Colonna R, Bernardi P, Di Lisa F. Imaging the mitochondrial permeability transition pore in intact cells. Biofactors. 1998;8:263–72.
Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta. 2009;1787:1395–401.
Giaime E, Yamaguchi H, Gautier CA, Kitada T, Shen J. Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening. PLoS ONE 2012;7:e40501.
Giacomello M, Pellegrini L. The coming of age of the mitochondria-ER contact: a matter of thickness. Cell Death Differ. 2016;23:1417–27.
Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol. 2012;13:566–78.
Naon D, Scorrano L. At the right distance: ER-mitochondria juxtaposition in cell life and death. Biochim Biophys Acta. 2014;1843:2184–94.
Raffaello A, Mammucari C, Gherardi G, Rizzuto R. Calcium at the center of cell signaling: interplay between endoplasmic reticulum, mitochondria, and lysosomes. Trends Biochem Sci. 2016;41:1035–49.
Pozzan T, Rudolf R. Measurements of mitochondrial calcium in vivo. Biochim Biophys Acta. 2009;1787:1317–23.
Kaczmarek-Hajek K, Lorinczi E, Hausmann R, Nicke A. Molecular and functional properties of P2X receptors-recent progress and persisting challenges. Purinergic Signal. 2012;8:375–417.
Smith JB, Smith L, Higgins BL. Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells. J Biol Chem. 1985;260:14413–6.
Solanes P, Heuze ML, Maurin M, Bretou M, Lautenschlaeger F, Maiuri P, et al. Space exploration by dendritic cells requires maintenance of myosin II activity by IP3 receptor 1. EMBO J. 2015;34:798–810.
Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, Molinski TF, et al. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron. 1997;19:723–33.
Moore CL. Specific inhibition of mitochondrial Ca++ transport by ruthenium red. Biochem Biophys Res Commun. 1971;42:298–305.
Crompton M, Ellinger H, Costi A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J. 1988;255:357–60.
Clarke SJ, McStay GP, Halestrap AP. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem. 2002;277:34793–9.
Batandier C, Leverve X, Fontaine E. Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Biol Chem. 2004;279:17197–204.
Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol. 2009;46:821–31.
Poston CN, Krishnan SC, Bazemore-Walker CR. In-depth proteomic analysis of mammalian mitochondria-associated membranes (MAM). J Proteom. 2013;79:219–30.
Rowland AA, Voeltz GK. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol. 2012;13:607–25.
Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol. 2006;174:915–21.
Rieusset J. The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: an update. Cell Death Dis. 2018;9:388.
Acknowledgements
We thank Novartis Pharma AG for providing SfA. This work was supported in part by grants from the CIHR (MOP-123400) and NSERC (RGPIN/06270-2019) to KYL and an Alberta Cancer Foundation graduate studentship to SN.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
NavaneethaKrishnan, S., Rosales, J.L. & Lee, KY. mPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca2+ uptake. Oncogene 39, 2797–2806 (2020). https://doi.org/10.1038/s41388-020-1188-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-020-1188-5
This article is cited by
-
Cyclin-dependent Kinase 5 and Neurodegenerative Diseases
Molecular Neurobiology (2024)
-
Cdk5 regulates IP3R1-mediated Ca2+ dynamics and Ca2+-mediated cell proliferation
Cellular and Molecular Life Sciences (2022)
-
PM2.5-Induced Programmed Myocardial Cell Death via mPTP Opening Results in Deteriorated Cardiac Function in HFpEF Mice
Cardiovascular Toxicology (2022)
-
Post-translational modifications of CDK5 and their biological roles in cancer
Molecular Biomedicine (2021)
-
CDK5RAP2 loss-of-function causes premature cell senescence via the GSK3β/β-catenin-WIP1 pathway
Cell Death & Disease (2021)